Inventor · disambiguated record
Anlai Wang
Also filed as: WANG ANLAI
36 granted patents·10 pending applications·271 citations·filing 2003–2024
97Inventor score
Top patents by PatentIndex Score
46 records- 0197US11492354B2Indazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Nov 8, 2022·8 cites·71 claims
- 0297US10934288B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Mar 2, 2021·13 cites·8 claims
- 0397US10435405B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Granted Oct 8, 2019·23 cites·16 claims
- 0497US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 0596US11607416B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Mar 21, 2023·7 cites·52 claims
- 0696US10752635B2Indazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 25, 2020·16 cites·67 claims
- 0796US10266530B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Granted Apr 23, 2019·24 cites·42 claims
- 0896US9580418B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·19 cites·64 claims
- 0994US9676750B2Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 13, 2017·18 cites·53 claims
- 1093US12384778B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2023·Granted Aug 12, 2025·1 cites·49 claims
- 1193US11795166B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 24, 2023·2 cites·26 claims
- 1293US9920032B2Heterocyclic compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·12 cites·31 claims
- 1393US9278950B2Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Mar 8, 2016·24 cites·55 claims
- 1492US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 1591US12083124B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2023·Granted Sep 10, 2024·1 cites·30 claims
- 1691US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 1790US7511050B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2007·Granted Mar 31, 2009·14 cites·110 claims
- 1888US10450296B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·25 claims
- 1987US7462624B2Purinone derivatives as HM74a agonistsINCYTE CORP·Filed 2007·Granted Dec 9, 2008·8 cites·81 claims
- 2084US7678798B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2005·Granted Mar 16, 2010·5 cites·35 claims
- 2182US11111247B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Sep 7, 2021·1 cites·48 claims
- 2280US11053215B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2019·Granted Jul 6, 2021·1 cites·12 claims
- 2380US7902205B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Mar 8, 2011·3 cites·36 claims
- 2480US2025057852A1Bicyclic heterocycles as fgfr inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2579US8268826B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2009·Granted Sep 18, 2012·3 cites·17 claims
- 2679US7576089B23-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2004·Granted Aug 18, 2009·8 cites·2 claims
- 2777US2023043959A1Piperidin-4-yl azetidine derivatives as jak1 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 2876US11229631B2Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2020·Granted Jan 25, 2022·0 cites·4 claims
- 2974US8039478B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Oct 18, 2011·1 cites·22 claims
- 3074US7863285B2Purinone derivatives as HM74A agonistsINCYTE CORP·Filed 2008·Granted Jan 4, 2011·1 cites·27 claims
- 3170US8703783B2Purinone derivatives as HM74A agonistsZHENG CHANGSHENG·Filed 2011·Granted Apr 22, 2014·2 cites·7 claims
- 3266US2024317744A1Bicyclic Ureas As Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3365US12441731B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 14, 2025·0 cites·54 claims
- 3465US8697870B23-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsXUE CHU-BIAO·Filed 2008·Granted Apr 15, 2014·0 cites·2 claims
- 3561US9067921B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsINCYTE CORP·Filed 2014·Granted Jun 30, 2015·0 cites·7 claims
- 3661US2014371216A1Purinone derivatives as hm74a agonistsINCYTE CORP·Filed 2014·Application pending·0 cites
- 3761US2025353842A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 3860US2014155377A13-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsXUE CHU-BIAO·Filed 2014·Application pending·0 cites
- 3958US2017050942A13-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsINCYTE CORP·Filed 2016·Application pending·0 cites
- 4058US2023203010A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 4157US8680104B2Piperazinylpiperidine derivatives as chemokine receptor antagonistsXUE CHU-BIAO·Filed 2012·Granted Mar 25, 2014·0 cites·9 claims
- 4256US9890162B2Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2017·Granted Feb 13, 2018·0 cites·70 claims
- 4353US2015231114A13-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptorsPFIZER·Filed 2015·Application pending·0 cites
- 4451US11591329B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Feb 28, 2023·0 cites·58 claims
- 4542US2004110287A1Multi-step method for the differentiation of insulin positive, glucose responsive cellsES CELL INT PTE LTD·Filed 2003·Application pending·0 cites
- 4640US8895571B2Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitorsINCYTE CORP·Filed 2012·Granted Nov 25, 2014·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Anlai Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →